Despite Bcl3’s well-recognised association with metastatic disease, recently attributed to its ubiquitous role in cancer cell migration, there is little evidence directly linking Bcl3 with the NF-κB mediated regulation of basal survival mechanisms in breast cancer [22,23,24]. The gene discussed is NFKB1; the disease is breast carcinoma.